Presentation and management of delayed aortic endograft infection.
Ben LiHooman HennesseyJohn FentonMohammad QaduraPublished in: BMJ case reports (2023)
A man in his 60s who underwent endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm 4 years ago presents with 1 week of abdominal pain, fever and leucocytosis. CT angiogram demonstrated an enlarged aneurysm sac with intraluminal gas and periaortic stranding consistent with infected EVAR. He was clinically unfit for an open surgical intervention due to his significant cardiac comorbidities, including hypertension, dyslipidaemia, type 2 diabetes, recent coronary artery bypass grafting and congestive heart failure secondary to ischaemic cardiomyopathy with an ejection fraction of 30%. Therefore, due to this significant surgical risk, he was treated with percutaneous drainage for the aortic collection and lifelong antibiotics. The patient is well 8 months following presentation with no signs of ongoing endograft infection, residual aneurysm sac enlargement, endoleak or haemodynamic instability.
Keyphrases
- abdominal aortic aneurysm
- coronary artery bypass grafting
- ejection fraction
- heart failure
- left ventricular
- abdominal pain
- type diabetes
- aortic stenosis
- case report
- aortic valve
- aortic dissection
- percutaneous coronary intervention
- coronary artery disease
- ultrasound guided
- randomized controlled trial
- pulmonary artery
- computed tomography
- abdominal aortic
- cardiovascular disease
- cardiac resynchronization therapy
- transcatheter aortic valve replacement
- room temperature
- magnetic resonance imaging
- glycemic control
- dual energy
- clinical trial
- pulmonary arterial hypertension
- ionic liquid